Transcription of INTERNATIONAL CLINICAL DIABETIC …
{{id}} {{{paragraph}}}
October 2002. INTERNATIONAL CLINICAL DIABETIC RETINOPATHY. DISEASE SEVERITY SCALE. DETAILED TABLE. Proposed Findings Observable upon Derivation from Risk Management Options*. Disease Dilated Ophthalmoscopy ETDRS Levels Assessment Severity Level No apparent No abnormalities Levels 10: DR Optimize medical therapy of Retinopathy absent glucose, blood pressure and lipids Mild Non- Microaneurysms Level 20: Very Optimize medical therapy of Proliferative only mild NPDR glucose, blood pressure and DIABETIC lipids Retinopathy Moderate More than just Levels 35,43: One year early Refer to an ophthalmologist Non- microaneurysms but moderate NPDR PDR: Optimize medical therapy of proliferative less than Severe less than 4:2.
October 2002 The goal of laser treatment is to reduce the rate of visual loss. Preoperatively, the ophthalmologist should assess macular edema, discuss side effects of treatment and risks of visual loss, and obtain informed consent from the
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
INFORMED CONSENT- LASER TREATMENT, Informed Consent, Laser, TREATMENT, BOARD OF CHIROPRACTIC EXAMINERS, BUPERSINST 1000.22B, United States Navy, Retrograde Intrarenal Surgery (RIRS) -, CONSENT TO RECEIVE RESTYLANE® INJECTION, State Board of Medical Licensure and, State Board of Medical Licensure and Supervision